Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,410 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00020111 | Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 3 | Apr 29, 2015 | clinicaltrials |
| NCT02097875 | Safety Study of a Fluorescent Marker to Visualize Cancer Cells | completed | Phase 1 | 21 | Blaze Bioscience Australia Pty LtdINDUSTRY | 1 | Apr 21, 2015 | clinicaltrials |
| NCT00544258 |
| Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005 |
| completed |
| Phase 1 |
| 8 |
| PeplinINDUSTRY |
| 1 |
| Feb 12, 2015 |
| clinicaltrials |
| NCT00003750 | Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors | completed | Phase 1 | 28 | Children's Oncology GroupNETWORK | 3 | Aug 8, 2014 | clinicaltrials |
| NCT00003935 | Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | completed | Phase 1 | 31 | Children's Oncology GroupNETWORK | 6 | Jul 28, 2014 | clinicaltrials |
| NCT00003597 | Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 16 | Children's Oncology GroupNETWORK | 2 | Jul 24, 2014 | clinicaltrials |
| NCT00742924 | Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | completed | Phase 1 | 24 | Children's Oncology GroupNETWORK | 4 | Jul 4, 2014 | clinicaltrials |
| NCT00008424 | Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants | completed | Phase 1 | 7 | Children's Oncology GroupNETWORK | 3 | May 5, 2014 | clinicaltrials |
| NCT00003141 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors | completed | Phase 1 | 94 | Children's Oncology GroupNETWORK | 3 | Mar 28, 2014 | clinicaltrials |
| NCT00004932 | STI571 in Treating Patients With Recurrent Leukemia | completed | Phase 1 | 31 | Children's Oncology GroupNETWORK | 7 | Feb 21, 2014 | clinicaltrials |
| NCT00006095 | Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | 20 | Children's Oncology GroupNETWORK | 2 | Feb 21, 2014 | clinicaltrials |
| NCT00006463 | Ecteinascidin 743 in Treating Children With Refractory Solid Tumors | completed | Phase 1 | 13 | Children's Oncology GroupNETWORK | 3 | Feb 21, 2014 | clinicaltrials |
| NCT00028899 | Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes | completed | Phase 1 | 47 | Children's Oncology GroupNETWORK | 3 | Feb 20, 2014 | clinicaltrials |
| NCT00006024 | Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma | completed | Phase 1 | 32 | Children's Oncology GroupNETWORK | 7 | Feb 13, 2014 | clinicaltrials |
| NCT00070200 | Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma | completed | Phase 1 | 31 | Children's Oncology GroupNETWORK | 2 | Feb 13, 2014 | clinicaltrials |
| NCT00107471 | Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma | terminated | Phase 1 / Phase 2 | 7 | Children's Oncology GroupNETWORK | 4 | Dec 10, 2013 | clinicaltrials |
| NCT00569036 | Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors | completed | Phase 1 | 63 | Bristol-Myers SquibbINDUSTRY | 1 | Aug 14, 2013 | clinicaltrials |
| NCT00004042 | Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Jul 18, 2013 | clinicaltrials |
| NCT00009698 | Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia | completed | Phase 1 | 1 | Children's Oncology GroupNETWORK | 6 | Jun 28, 2013 | clinicaltrials |
| NCT00098995 | Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | completed | Phase 1 | 22 | Peter MacCallum Cancer Centre, AustraliaOTHER | 2 | Jun 26, 2013 | clinicaltrials |
| NCT00927875 | A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer | completed | Phase 1 | 5 | Bristol-Myers SquibbINDUSTRY | 5 | Jun 3, 2013 | clinicaltrials |
| NCT00650949 | Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma | terminated | Phase 1 / Phase 2 | 20 | Gilead SciencesINDUSTRY | 1 | May 3, 2013 | clinicaltrials |
| NCT00666926 | Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms | completed | Phase 1 | 99 | Verastem, Inc.INDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
| NCT00959946 | Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | PfizerINDUSTRY | 6 | Feb 22, 2013 | clinicaltrials |
| NCT00636922 | Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia | unknown | Phase 1 | 40 | Bayside HealthOTHER_GOV | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00457119 | Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients | completed | Phase 1 | 69 | Novartis PharmaceuticalsINDUSTRY | 3 | Feb 12, 2013 | clinicaltrials |
| NCT00003191 | Fenretinide in Treating Children With Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 2 | Feb 7, 2013 | clinicaltrials |
| NCT00003370 | Irofulven in Treating Children With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 3 | Feb 5, 2013 | clinicaltrials |
| NCT00003765 | O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 3 | Feb 5, 2013 | clinicaltrials |
| NCT00005577 | Gemcitabine in Treating Children With Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 2 | Feb 5, 2013 | clinicaltrials |
| NCT00002912 | Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia | completed | Phase 1 | 3 | National Cancer Institute (NCI)NIH | 3 | Feb 1, 2013 | clinicaltrials |
| NCT00635193 | Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin) | completed | Phase 1 / Phase 2 | 138 | AbbVie (prior sponsor, Abbott)INDUSTRY | 9 | Jan 18, 2013 | clinicaltrials |
| NCT01472003 | An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types | completed | Phase 1 | 18 | AbbVie (prior sponsor, Abbott)INDUSTRY | 1 | Jan 14, 2013 | clinicaltrials |
| NCT01716364 | Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome | unknown | Phase 1 | 6 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT00788333 | Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer | completed | Phase 1 / Phase 2 | 40 | Bristol-Myers SquibbINDUSTRY | 5 | Jul 13, 2012 | clinicaltrials |
| NCT00793897 | Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 21 | Bristol-Myers SquibbINDUSTRY | 3 | Jul 13, 2012 | clinicaltrials |
| NCT00779337 | Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas(EPL) | completed | Phase 1 | 8 | Queensland Institute of Medical ResearchOTHER | 1 | May 22, 2012 | clinicaltrials |
| NCT00234169 | A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone | completed | Phase 1 / Phase 2 | 30 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | May 10, 2012 | clinicaltrials |
| NCT00745550 | A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis | completed | Phase 1 / Phase 2 | 55 | S*BIOINDUSTRY | 2 | Apr 20, 2012 | clinicaltrials |
| NCT01052142 | Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma | completed | Phase 1 | 12 | Lipotek Pty LtdINDUSTRY | 1 | Apr 11, 2012 | clinicaltrials |
| NCT00881946 | Repeat Dose Safety Study for Compound to Treat Hematologic Cancer | completed | Phase 1 / Phase 2 | 73 | AccentureINDUSTRY | 3 | Apr 4, 2012 | clinicaltrials |
| NCT00437203 | PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine | terminated | Phase 1 | 43 | PfizerINDUSTRY | 2 | Apr 3, 2012 | clinicaltrials |
| NCT00557505 | A Study Of PF-03732010 In Patients With Advanced Solid Tumors | completed | Phase 1 | 43 | PfizerINDUSTRY | 3 | Mar 26, 2012 | clinicaltrials |
| NCT00022451 | Tipifarnib in Treating Young Patients With Refractory Leukemia | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 3 | Mar 15, 2012 | clinicaltrials |
| NCT00949624 | CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors | completed | Phase 1 | 50 | Arog Pharmaceuticals, Inc.INDUSTRY | 2 | Jan 19, 2012 | clinicaltrials |
| NCT00960557 | Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden(OXi4503) | completed | Phase 1 | 16 | Mateon TherapeuticsINDUSTRY | 1 | Aug 23, 2011 | clinicaltrials |
| NCT00630110 | Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 172 | Nereus Pharmaceuticals, Inc.INDUSTRY | 6 | Aug 16, 2011 | clinicaltrials |
| NCT00431990 | A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma | unknown | Phase 1 / Phase 2 | 40 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Aug 12, 2011 | clinicaltrials |
| NCT00625430 | A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer(FP253-GDEPT) | unknown | Phase 1 | 18 | Biotech Equity Partners Pty LtdINDUSTRY | 1 | Jul 11, 2011 | clinicaltrials |
| NCT00753727 | Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma(SUNXRT) | unknown | Phase 1 / Phase 2 | 26 | Australasian Sarcoma Study GroupOTHER | 1 | Jun 23, 2011 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials